UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $1.3M of United Therapeutics Corporation
Sold$1,333,150
$222.19Price
6,000Shares
−14%Stake
What UTHR did after the filing
- The stock from Mon, Sep 25 open, $222.14
- +2.7%
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Nov 6 close.
Traded Thu, Sep 21. Filed Fri, Sep 22, 4:30 PM ET, after the close. Returns use the Sep 25 open and the Nov 6 close. Not investment advice.